Wills Eye Hospital/Mid Atlantic Retina — Philadelphia, Pennsylvania

Wills Eye Hospital/Mid Atlantic Retina is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Wills Eye Hospital/Mid Atlantic Retina has participated in 2 clinical trials.

Therapeutic areas: Stargardt's Macular Dystrophy, Age-related Macular Degeneration, Cataract.

Sponsors: Astellas Pharma Global Development, Inc., National Eye Institute (NEI).

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wills Eye Hospital/Mid Atlantic Retina?

Wills Eye Hospital/Mid Atlantic Retina has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wills Eye Hospital/Mid Atlantic Retina conducted?

Wills Eye Hospital/Mid Atlantic Retina has 2 clinical trials on record. Their work covers Stargardt's Macular Dystrophy, Age-related Macular Degeneration, Cataract.

Is Wills Eye Hospital/Mid Atlantic Retina accredited by Crixeo Health?

Wills Eye Hospital/Mid Atlantic Retina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wills Eye Hospital/Mid Atlantic Retina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.